🇺🇸

US SEC Filing Intelligence

· daily

New Federal Contractors — June 04, 2026

The four contracts analyzed total $3.08 billion in obligations, all from civilian agencies, with zero defense-related awards. The dominant theme is a massive, single $2.59 billion Department of Homeland Security award to FISHER SAND & GRAVEL CO, which accounts for 84% of total value and is the only bullish signal (strength 7/10). However, this award lacks pricing, competition, and revenue detail, creating significant uncertainty. Leidos, Inc. secured a $234.9 million firm-fixed-price IT support contract from CMS, a neutral signal reinforcing its competitive position in civilian IT services. The remaining two awards—NW CONSTRUCTION, INC ($139.3M, Interior) and SURATECH LLC ($113.3M, DOE)—are neutral, with the latter being a long-term management contract for a government-owned facility. Key risk: the FISHER SAND & GRAVEL award’s opacity and lack of public company exposure limit direct investment actionability.

4 total filings
· daily

Significant Contract Modifications ($10M+) — June 04, 2026

The four contract modifications analyzed, totaling $3.08 billion, are entirely civilian in nature, with zero defense-related awards. The dominant signal is a massive $2.59 billion sole-source award to FISHER SAND & GRAVEL CO from the Department of Homeland Security, representing 84% of total obligation value and carrying a bullish 7/10 signal strength. However, the lack of pricing, competition, or revenue data for this award introduces significant uncertainty. The other three contracts—Leidos, Inc. ($234.9M), NW CONSTRUCTION, INC ($139.3M), and SURATECH LLC ($113.3M)—are neutral signals with lower materiality. Key risk: the FISHER SAND & GRAVEL award's opaque terms and the fact that it is a civilian contract (DHS) rather than defense, making it more vulnerable to budget shifts or continuing resolution (CR) impacts. Investors should watch for outlay data on the FISHER contract and Leidos' CMS renewal prospects.

4 total filings
· daily

Contract Deobligations Alert — June 04, 2026

The digest covers $3.08 billion in total obligations across four civilian agency contracts, with zero defense-related awards. The dominant signal is the $2.59 billion sole-source award to FISHER SAND & GRAVEL CO from the Department of Homeland Security, which accounts for 84% of total value and carries a high materiality bullish signal, though the lack of public disclosure on pricing terms and competitive moat introduces execution risk. Leidos, Inc. secured a $234.9 million firm-fixed-price IT contract from HHS/CMS, reinforcing its competitive position in healthcare IT services but with near-completion status and medium pricing risk. A $139.3 million Interior modification for NW CONSTRUCTION, INC and a $115.7 million DOE GOCO facility award to private nonprofit SURATECH LLC are neutral signals with limited direct investment impact. Key watch items include the opaque terms and protest vulnerability of the FISHER SAND & GRAVEL contract and Leidos’ upcoming CMS renewal cycle.

4 total filings
· daily

Contract Option Exercises — June 04, 2026

The digest covers $3.08B in total obligations across four civilian-agency contract actions on June 4, 2026, with zero defense-related awards. The dominant signal is a massive $2.59B Department of Homeland Security award to FISHER SAND & GRAVEL CO, which accounts for 84% of total value and carries a bullish 7/10 signal strength, though the company is private and lacks public revenue data. A $234.9M Leidos IT services contract with CMS shows stable civilian IT demand but is near completion. The aggregate is heavily skewed by one outsized award, creating concentration risk, and the absence of defense contracts limits sector-wide implications for defense-focused portfolios. Key watch items include Leidos' CMS contract renewal and DOE budget allocations for SURATECH LLC's TJNAF facility.

4 total filings
· daily

Federal IT & Cybersecurity Contracts — June 04, 2026

This digest covers a single $234.9M firm-fixed-price IT services delivery order awarded to Leidos, Inc. by the Department of Health and Human Services (CMS), with zero defense-related contracts in the period. The dominant theme is civilian healthcare IT modernization, with Leidos reinforcing its competitive position in a full-and-open competition. The highest-conviction signal is neutral: the contract is near completion (2018-2023) with only $112M outlayed, implying potential under-execution or delayed obligations. A key risk is the fixed-price pricing structure transferring cost risk to Leidos, though IT services margins are typically manageable.

1 total filings
· daily

All HHS Contracts — June 04, 2026

This digest covers a single $234.9M firm-fixed-price IT services delivery order awarded to Leidos, Inc. by the Department of Health and Human Services (HHS) via the Centers for Medicare & Medicaid Services (CMS). The contract is entirely civilian, with no defense-related exposure, and represents a stable, near-completion award from 2018 to 2023. The highest-conviction signal is neutral: Leidos' competitive win in a full-and-open competition reinforces its IT services moat, but the contract is mature with only $112M outlayed, implying limited near-term revenue upside. A key risk is the absence of follow-on awards or renewal signals, which could create a revenue gap for Leidos' HHS/CMS segment.

1 total filings
· daily

All DOE Contracts — June 04, 2026

The sole contract analyzed for June 4, 2026, is a $113.3M Department of Energy (DOE) award to SURATECH LLC for managing the Thomas Jefferson National Accelerator Facility (TJNAF). This is a purely civilian, non-defense contract with a neutral signal strength (4/10) and low materiality (2/10) for public markets, as SURATECH is a private nonprofit. The cost-plus-award-fee structure reduces profit risk but limits upside, and the 5-year term signals stable, mission-critical DOE funding for nuclear physics R&D. The key risk is the lack of direct public equity exposure, though subcontractors or adjacent firms may benefit. No bullish or bearish signals were identified, making this digest a baseline observation of DOE facility management contracting.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — June 04, 2026

This digest covers four contracts totaling $3.08 billion in obligations, all from civilian agencies with zero defense-related awards. The dominant event is the Fisher Sand & Gravel Co. $2.59 billion award from the Department of Homeland Security, which anchors the period as a high-conviction bullish signal for civilian infrastructure and border security spending. The other three awards—Leidos’ $234.9M CMS IT services contract (near completion), NW Construction’s $139.3M Interior modification, and Suratech LLC’s $113.3M DOE facility management agreement—are neutral to low materiality. Key risk is the lack of defense exposure during a period when CR uncertainty often depresses civilian spending, though DHS’s mega-award suggests strong budget momentum for physical infrastructure. Watch for Fisher Sand & Gravel’s execution against this contract, as it is a private company with limited public equity ties.

4 total filings
· daily

High-Value Federal Grants ($5M+) — June 04, 2026

The four contracts analyzed total $3.08 billion in obligations, with zero defense-related awards, signaling a purely civilian-focused procurement period dominated by the Department of Homeland Security (DHS). The highest-conviction signal is the $2.59 billion sole-source award to FISHER SAND & GRAVEL CO from DHS, representing 84% of total value, but the lack of public company exposure limits direct investment implications. The only publicly traded entity, Leidos, Inc., secured a $234.9 million IT support contract from HHS/CMS, which is near completion and offers neutral near-term signals. A key risk is the concentration of awards to a single private firm and the absence of defense contracts, which may indicate a lull in defense spending or a shift toward civilian priorities. Investors should monitor DHS budget execution and Leidos' re-compete opportunities for IT services at CMS.

4 total filings
· daily

DOE Energy Grants — June 04, 2026

The sole contract analyzed, a $113.3M DOE award to SURATECH LLC for managing the Thomas Jefferson National Accelerator Facility, represents a civilian, mission-critical GOCO R&D contract rather than a defense procurement. The aggregate stream is entirely non-defense, with a neutral signal strength of 4/10 and zero bullish or bearish signals. The highest-conviction takeaway is the durability of DOE R&D facility funding, though the private nature of the contractor limits direct equity implications. Key risk is the absence of a competitive signal and low materiality for public markets, with no clear catalyst for publicly traded beneficiaries.

1 total filings
· daily

General Federal Contracts — June 04, 2026

This digest covers $3.08 billion in total obligations across 4 contracts, all civilian (0 defense-related), with an average signal strength of 5.3/10. The dominant theme is a massive, single-award $2.59B contract from the Department of Homeland Security to FISHER SAND & GRAVEL CO, which accounts for 84% of total value and is the only bullish signal (strength 7/10). However, data gaps on pricing, competition, and revenue for this award introduce execution and concentration risk. Leidos, Inc. secured a $234.9M firm-fixed-price IT support contract from HHS/CMS, reinforcing its competitive position in civilian IT services, though the contract is near completion. The remaining awards to NW CONSTRUCTION, INC ($139.3M, DOI) and SURATECH LLC ($113.3M, DOE) are neutral, with SURATECH's cost-plus contract for a DOE R&D facility offering low profit risk but limited upside. Key watch items include Leidos' renewal prospects at CMS and the lack of transparency around Fisher Sand & Gravel's contract specifics.

4 total filings
· daily

S&P 500 Technology Sector SEC Filings — June 04, 2026

The June 4 filing batch reveals a bipolar tech sector where high-growth companies like CrowdStrike, Planet Labs, and GameSquare are delivering outsized top-line gains (25-137% YoY) but face headwinds from rising costs, negative cash flow dynamics, or dilutive financing. A dominant thematic is the convergence of activist/transaction-related filings—three Genco Shipping filings detail a hostile takeover battle, while Pasqal pursues a SPAC merger at a $2B valuation. Period-over-period data shows margin compression across multiple filers: CrowdStrike's subscription gross margin improved slightly (+120 bps YoY) but professional services margin deteriorated, while Planet Labs' non-GAAP gross margin is guiding down 300-700 bps QoQ. Insider trading activity is notably absent from these filings, but capital allocation signals are rich—CrowdStrike repurchased $175.6M in shares and spent $881.4M on acquisitions, while Planet Labs redeemed warrants for $108M. Sentiment is mixed across the portfolio with 7 mixed, 4 neutral, 2 negative, and 1 positive filings (Imunon), and the average materiality score of 6.7/10 indicates high relevance for investors.

6 high priority 9 medium 15 total filings
· daily

Nasdaq 100 Stocks SEC Filings — June 04, 2026

The 11 NASDAQ-100 filings reveal a stark tension between aggressive capital deployment for AI infrastructure and defensive shareholder activism in the shipping sector. Alphabet's massive $80 billion equity raise, including a $10 billion Berkshire Hathaway private placement, underscores an industry-wide pivot to front-load AI capex, with Google Cloud revenue surging 63% YoY and backlog nearly doubling to $460 billion, though the 22% overall revenue growth is accompanied by significant dilution risk and a debt balance exceeding $100 billion. Meanwhile, Genco Shipping is fighting a hostile takeover bid from Diana Shipping at $24.80/share, which represents a ~7% discount to its own NAV estimate, drawing attention to deep value and activist dynamics in the commodity-transport space. On the biotech front, Imunon secured a $10 million financing with no warrants to advance its Phase 3 ovarian cancer trial, where updated Phase 2 data shows a median overall survival improvement to 14.7 months (from 11.1 months), a 32% gain. At the smaller-cap end, Octave Intelligence reported tepid 1% revenue growth and a 20% net income decline, revealing margin pressure from rising costs. The other filings (BNY Mellon funds, Watu Metals SPAC, United Community Banks merger, AIM ImmunoTech Ebola research) are largely procedural or low-materiality, but the aggregate picture points to a market rewarding AI-infrastructure bets while punishing slow-growth or contested-value situations.

6 high priority 5 medium 11 total filings
· daily

S&P 500 Financials Sector SEC Filings — June 04, 2026

The 50 filings from S&P 500 Financials and related sectors reveal a bifurcated market: capital-intensive and industrial-linked companies (Ciena, Columbus McKinnon, Pyxus) show strong revenue growth, while early-stage biotechs and SPACs continue to burn cash with widening losses. A clear theme is the surge in M&A and capital markets activity, with several transformative deals (Gentherm/Modine, Somnigroup/Leggett & Platt, TruBridge/IKS) and large debt offerings (QXO's $3B, Marsh & McLennan's $4.25B credit facility) signaling confidence in long-term growth. However, insider funding reliance (NextTrip), Nasdaq non-compliance (Smith-Midland), and significant goodwill impairments (Columbus McKinnon's $200M) highlight persistent risks. Period-over-period data shows revenue growth ranging from 8.5% (PagSeguro) to 39.5% (Ciena), but margin compression is widespread, with several companies reporting operating losses or declining gross margins. The most critical development is the wave of shareholder activism and proxy fights (Genco vs. Diana Shipping), alongside regulatory milestones for nuclear fusion (General Fusion) and GLP-1 weight loss maintenance (Fractyl Health), which present high-conviction opportunities.

20 high priority 30 medium 50 total filings
· daily

S&P 500 Consumer Staples Sector SEC Filings — June 04, 2026

This batch of 50 S&P 500 Consumer Staples filings reveals a sector bifurcating between scale-driven efficiency and strategic repositioning. Key period-over-period trends show a clear divergence: **Five Below** posted explosive 32.5% YoY revenue growth and tripled net income, while **lululemon athletica** saw net income plunge 38% on a 4.3% revenue rise, underscoring the risk of margin compression from cost inflation and shifting consumer preferences. The most critical development is **lululemon's** negative full-year revenue guidance (-0-1%) and operating margin contraction of 730 bps, signaling structural headwinds. Conversely, significant capital deployment through **Marsh & McLennan's** $4.25 billion credit facility upsize and **Five Below's** aggressive expansion indicate robust corporate balance sheet health. However, insider activity remains notably absent across these filings, a neutral signal, while capital allocation focuses on organic growth and debt optimization over aggressive buybacks. The primary portfolio-level pattern is the 'operational efficiency playbook' – companies like **Lamb Weston** and **Cushman & Wakefield** are restructuring/refinancing to defend margins, while winners like **Five Below** are capitalizing on strong consumer demand in value-oriented segments.

21 high priority 29 medium 50 total filings
· daily

S&P 500 Industrials Sector SEC Filings — June 04, 2026

The 50 filings from S&P 500 Industrials and related sectors reveal a market bifurcated between aggressive capital deployment for growth (Alphabet's $80B raise, Gentherm's transformative acquisition) and defensive positioning via spin-offs (Resideo's ADI separation) and debt refinancing (Patterson-UTI). Period-over-period data shows strong revenue momentum in select areas, with ArcBest's Asset-Light segment growing 32% YoY and Alphabet's Cloud surging 63% YoY, but margin pressures are evident in asset-heavy businesses. A wave of proxy contests and M&A activity (Genco Shipping vs. Diana, Medallion Financial vs. ZimCal, Leggett & Platt/Somnigroup) signals heightened shareholder activism and industry consolidation. Insider and related-party financing at NextTrip and Nu Ride point to liquidity stress for smaller caps, while large-cap IPOs (Applied Aerospace) and reverse stock splits (Medicus Pharma) indicate capital structure realignment. The most critical development is Alphabet's massive equity raise, which, while funding AI infrastructure, introduces significant dilution risk and signals a potential peak in capital intensity for hyperscalers.

21 high priority 29 medium 50 total filings
· daily

S&P 500 Energy Sector SEC Filings — June 04, 2026

The five filings present a fragmented landscape within the broader S&P 500 Energy context, with a notable skew toward non-energy issuers (Real Brokerage, BRT Apartments, Stoke Therapeutics, Idaho Copper) and one tangential energy-adjacent filing (Inspira Technologies). However, the collection reveals critical capital allocation and financial distress themes relevant to the energy sector. Idaho Copper Corp (COPR) is attempting an IPO amidst a rapidly deteriorating financial position, with its accumulated deficit worsening by $2.62 million (23% increase from $11.39M to $14.01M) and heavy reliance on related-party debt, signaling extreme distress [BEARISH]. In contrast, Real Brokerage Inc. is pursuing an aggressive acquisition strategy, showing explosive agent growth (50% CAGR since Q1 '23) and strong revenue ($2.1B LTM), but with acquisition completion risk [BULLISH/BEARISH]. The BRT Apartments acquisition of a Florida property for $80M, financed by a low 2.91% HUD mortgage, is a measured capital deployment in a challenging market [MIXED]. Notable shareholder dissent at Stoke Therapeutics (27% withhold votes for a director and 27.1% against say-on-pay) signals governance concerns. Inspira Technologies' shelf registration to issue subsidiary shares suggests upcoming dilution but no immediate operational read-through. The key portfolio-level pattern is a divergence between companies with strong growth trajectories and those with deteriorating fundamentals and shareholder governance issues.

2 high priority 3 medium 5 total filings
· daily

US Material Events SEC 8-K Filings — June 04, 2026

The 50 filings reveal a mixed landscape with significant capital market activity, including large-scale refinancings (Marsh & McLennan's $4.25B credit facility, Cimpress's $1.35B refinancing), debt restructurings (Accuray's full repayment, CONMED's $645M note repurchase), and equity-linked financings (Syndax's $250M convertible notes). Several companies are pursuing strategic transformations: Resideo's ADI spin-off, Trulieve's deconsolidation, and Applied Aerospace's IPO preparations. Governance and compensation issues are prominent, with notable shareholder dissent at Sarepta (33% against say-on-pay), iHeartMedia (15.6% against), and BioMarin (13% against). Insider funding and liquidity concerns persist at NextTrip (related-party loans) and Avalon GloboCare (high-cost promissory note). Sector themes include increased leverage in insurance/brokerage, cannabis restructuring, and biotech equity plan expansions. No period-over-period revenue or margin trends are available from the filings, as most are event-driven 8-Ks without financial statements.

50 high priority 50 total filings
· daily

Dow Jones 30 Stocks SEC Filings — June 04, 2026

The 50 filings from Dow 30 constituents and related companies reveal a mixed picture for June 4, 2026, with clear themes of operational bifurcation, aggressive capital allocation, and significant governance activity. Period-over-period data shows divergent performance: CrowdStrike achieved a remarkable turnaround with net income swinging from a -$104.3M loss to a +$27.8M profit on 25.6% revenue growth, while Torrid Holdings saw net income collapse 93% YoY to $0.4M on a 7.6% sales decline. A major theme is the aggressive pursuit of growth through M&A and capital raises, highlighted by Spring Valley Acquisition Corp. III's $1B SPAC merger with General Fusion and Enovix Corp's $50M AI infrastructure funding, though several deals carry high execution risk. Insider activity is notably absent from these filings, but shareholder dissent is a recurring risk, with significant opposition votes at Evolent Health (18.7M against compensation plan), OneSpaWorld (52.5M withhold for a director), and CV Sciences (failed reverse split). Capital allocation is mixed, with CrowdStrike aggressively buying back $175.6M in shares while Kohl's struggles with declining revenue and rising inventory. The most critical development is the wave of leadership transitions and strategic pivots, including Ekso Bionics' planned divestiture and Knight-Swift's co-founder retirement, which could signal sector-wide shifts in strategy and management focus.

21 high priority 29 medium 50 total filings
· daily

US SEC Filings Daily Market Digest — June 04, 2026

Today's filings reveal a market bifurcated between strong operational momentum and significant financial engineering risks. A clear theme is the aggressive use of leverage and capital markets for transformative M&A, with QXO pricing $3.0B in notes for its TopBuild acquisition, Columbus McKinnon reporting a 24% revenue surge from the Kito Crosby deal but a $229.5M net loss due to a $200M goodwill impairment, and Gentherm announcing a Reverse Morris Trust acquisition to create a $2.6B revenue entity. Conversely, several companies show deteriorating fundamentals: X-Energy's net loss ballooned to $166.2M despite doubling revenue, CrowdStrike's cash position fell 12.9% due to acquisition spending, and PagSeguro's core transaction revenue declined 11.2% YoY. Insider financing and liquidity concerns are evident at NextTrip, which borrowed $200K from a director at 7.5% interest with a June 30 maturity, and America Great Health, which remains deeply insolvent with a $5.8M deficit. On the positive side, Ciena posted exceptional results with 39.5% revenue growth and raised guidance, Fractyl Health reported promising one-year data for its Revita procedure, and Genco Shipping is defending against an inadequate takeover bid while highlighting its strong dividend track record. The regulatory calendar is active with several key deadlines approaching, including the Leggett & Platt/Somnigroup merger clearing HSR review and the TruBridge acquisition vote scheduled for July 7.

20 high priority 30 medium 50 total filings